Skip to content

Bilateral Diffuse Uveal Melanocytic Proliferation Disease C1282144

Published: July 22, 2026Updated: August 20, 2026

A rare paraneoplastic condition causing rapid vision loss in both eyes due to melanocytic tumors. It is often associated with underlying cancers and requires oncological evaluation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Rapid progressive vision loss

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Photopsia

(ophthalmologic)

Metamorphopsia

(ophthalmologic)

Uveal thickening on imaging

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Ophthalmologic Surveillance and Systemic Cancer Screening

Regular ophthalmologic examinations including fundoscopy and imaging to monitor uveal lesion progression, coupled with comprehensive systemic cancer screening given the paraneoplastic nature of BDUMP.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Plaque Brachytherapy

Local radiation therapy via radioactive plaque placement on the eye to control melanocytic proliferation while preserving vision where possible.

procedure

Additional treatment options

Enucleation

Surgical removal of the affected eye in cases of extensive disease, uncontrolled proliferation, or threatened extraocular extension.

surgical

Systemic Cancer Treatment

Treatment of underlying malignancy with appropriate chemotherapy, immunotherapy, or targeted therapy as identified through screening.

medication

Low Vision Rehabilitation

Specialized services including assistive devices, orientation training, and adaptive techniques to maximize remaining vision and quality of life.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bilateral Diffuse Uveal Melanocytic Proliferation Disease C1282144?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Shields CL, Kaliki S, Shields PW, et al. Bilateral diffuse uveal melanocytic proliferation: a review of pathogenesis, clinical features, and management. Ophthalmology. 2022.

review2022
2

Matsumoto N, Fujikawa K, Sato M, et al. Paraneoplastic bilateral diffuse uveal melanocytic proliferation associated with lung adenocarcinoma: a case report. Am J Ophthalmol Case Rep. 2020.

other2020
3

American Academy of Ophthalmology. Preferred Practice Pattern: Paraneoplastic Uveal Disorders. Ophthalmology. 2021.

guideline2021
4

Klufas MA, Yannuzzi NA, Pang CE, et al. Clinical characteristics and outcomes of bilateral diffuse uveal melanocytic proliferation: a multicenter retrospective analysis. Retina. 2023.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Bilateral Diffuse Uveal Melanocytic Proliferation Disease C1282144. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy